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Abstract
Introduction: Celiac disease can be severe and associated with progressive malabsorption and
death. A subset of patients may develop subepithelial collagen deposition, a condition referred to
as collagenous sprue.
Case presentation: We report a case of a 46-year-old female who was previously diagnosed as
having seronegative arthritis and inflammatory bowel disease, and three years later after the initial
diagnosis she was histologically confirmed to have celiac disease in association with collagenous
sprue, another underlying malabsorptive disorder.
Conclusion: Although the precise relationship between celiac disease and collagenous sprue has
been debated and remains controversial, it should be considered among the differential diagnoses
of chronic diarrhea with progressive malabsorption.
Introduction
Celiac disease (CD) is a disorder characterized by mucosal
inflammation and villous atrophy of small bowel, leading
to symptoms of malabsorption such as steatorrhea,
weight loss or other signs of nutrient or vitamin defi-
ciency. Withdrawal of gluten-containing foods results in
resolution of the mucosal lesions and symptoms. The
diagnosis is presumptively established when there is con-
cordance between the serologic results and the biopsy
findings. It is confirmed when symptoms resolve subse-
quently on a gluten-free diet.
Collagenous sprue (CS) is a rare disease of the small
bowel, which is characterized by complete atrophy of
mucosal villi and excessive collagen deposition in the
lamina propria. It may cause a life threatening clinical pic-
ture. Patients may also present with a number of non-gas-
trointestinal manifestations; neuropsychiatric, rheumatic
and metabolic disorders. Patients with CS generally do
not respond to a gluten-free diet and often have a poor
prognosis, but luckily some of them experience complete
clinical improvement.
Case presentation
A 46-year-old Kirghiz female was admitted with the previ-
ous diagnosis of seronegative arthritis and inflammatory
bowel disease. Various nonsteroidal anti-inflammatory
drugs, prednisone, sulfasalazine, and two courses of anti-
TNF alpha were prescribed earlier by her physician for
symptomatic treatment.
At admission to our clinic, she presented with depressive
symptoms and anxiety. She complained of weight loss
(loss of 15 kg over a period of 1 to 2 months), diarrhea,
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weakness, and fatigue. She was severely cachexic with a
significantly lower BMI (12.11 kg/m2). Physical examina-
tion revealed bilateral swelling of knee joints, skin rashes
over the lower legs and the presence of pitting after apply-
ing pressure to pretibial areas. Movements of involved
joints were painless and there was no definite restriction
in the range of movements. The liver was palpated 1 cm
below the costal margin in the right upper quadrant.
Splenomegaly and enlargement of lymph nodes were not
noticed.
Complete blood count at admission showed the follow-
ing values: Hb: 11.2 g/dL, Hct: 32.6%, WBC: 7.500/mm3,
Plt: 351.000/mm3. The erythrocyte sedimentation rate
was 4 mm/h, and the level of C-reactive protein was 13.6
mg/L. The routine biochemical tests revealed
hyponatremia (126,6 mmol/L, normal: 135-145),
hypokalemia (2.59 mmol/L, normal: 3.5-5.5), low ion-
ized calcium (3.18 mg/dL, normal: 4.2-5.4), magnesium
(1.37 mg/dL, normal: 1.9-2.7) and phosphate concentra-
tions (1.2 mg/dL, normal: 2.6-4.5), severe hypoproteine-
mia (4.78 g/dL, normal: 6.4-8.3), hypoalbuminemia (1.2
g/dL, normal: 3.5-5.5), elevated levels of alkaline phos-
phatase (298 U/L, normal: 38-155) and gammaglutamyl
transpeptidase (127 U/L, normal: 7-32). The other bio-
chemical results were within normal limits and routine
urine examination was normal. The patient had a 24-hour
urinary protein collection, which showed a 24-hour pro-
tein measurement of 67.50 mg. This was confirmed on a
repeat sample. Thyroid function tests showed FT3 level of
0.62 pg/mL at the lower limit of the normal range (nor-
mal: 0.60-1.95), decreased FT4 level of 4.40 ng/dL (nor-
mal: 5.00-11.50) and normal TSH concentration of 1.14
μIU/mL (normal: 0.30-4.00). The concentrations of PTH
(230 pg/mL, normal: 10-65) and 25-hydroxyvitamin D (4
ng/mL, normal: 10-40) were also measured. Electrophore-
sis of alkaline phosphatase isoenzymes revealed elevated
levels of liver isoenzyme. To view the status of hypotha-
lamic-pituitary-adrenal function synachten test was per-
formed, which excluded the possibility of adrenal
insufficiency. The serological tests for various infectious
agents (HBsAg, anti HBC, anti HIV 1+2, Treponemal tests,
Brucella Ig G/M antibody levels, TORCH titers) were
found to be negative. Ig G, A, M levels were within normal
limits. AMA, c-ANCA, p-ANCA, anti-LKM-1 were not
detected. She was found to have positive ANA in a titer of
1/80 with granular and homogeneous pattern. Positive
IgA endomysial antibody (1/80 titer) and IgG antigliaden
antibody (98.50 RU/ml) levels were also detected.
Radiographs of involved joints revealed no evidence of
bony erosions, chondrocalcinosis or deformity. Findings
on electrocardiogram, echocardiogram, and chest radio-
graph, and magnetic resonance cholangiopancreatogra-
phy images were all normal. Abdominal ultrasonography
displayed enlarged liver (155 mm in maximum cranial-
caudal extent) and increased echogenicity of the liver
parenchyma (Grade 1). On thoracoabdominopelvic com-
puted tomographic examination multiple mesenteric
lymph nodes, with a largest diameter of 18 × 10 mm, were
detected. DEXA scan of the lumbar spine and right hip
showed low bone mineral density (BMD) with a total T
score of - 5.7 and 4.9, respectively.
To examine the upper part of the gastrointestinal system
esophagogastroduodenoscopy was done, which revealed
grade 1 esophagitis, hypotonic LES, gastritis, erosive bul-
bitis and hyperemia in the postbulbar duodenum. To con-
firm the initial diagnosis of inflammatory bowel disease
colonoscopy was performed. Findings other than nonspe-
cific hyperemia of the ileal mucosa were not present. Mul-
tiple biopsies were obtained from both upper and lower
gastrointestinal tract at the time of endoscopic evaluation.
CD was histologically confirmed by duodenal biopsies,
which revealed total villous atrophy of duodenal mucosa
and regenerative hyperplasia. Increased cellularity of
plasma cells and lymphocytes in the lamina propria and
surface epithelium were observed. Histological examina-
tion of the excised tissue also revealed amorphous eosi-
nophilic deposition in the lamina propria and in the wall
of some vessels and glands, which was previously found
typical for amyloid (Figure 1). However, congo-red and
crystal violet staining prosedures and immunohistochem-
ical studies showed no amyloid protein. Neither kappa
nor lambda monoclonality was detected in lymphoplas-
mocytoid cells, immunohistochemically. Loose light-
green staining of the deposition by trichrome staining was
the unique positive finding (Figure 2). In the light of these
Eosinophilic material deposition in the lamina propria (Hema- toxylin and Eosin staining, 200× magnification) Figure 1
Eosinophilic material deposition in the lamina pro-
pria (Hematoxylin and Eosin staining, 200× magnifi-
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findings, collagenous sprue due to long-standing celiac
disease was the last diagnosis, histologically. Specimens
obtained from terminal ileum revealed chronic inflam-
mation and subtotal villous atrophy of ileal mucosa.
Our patient suffered from anorexia and poor oral intake.
To increase caloric intake to gain weight total parenteral
nutrition was administered by cyclic infusions. After sev-
eral days diarrhea improved. She was asked to avoid tak-
ing gluten and her complaints abated and did not persist.
Discussion
The combination of a careful history and physical exami-
nation and a few diagnostic tests (serologic results and the
biopsy findings) can result in establishing the diagnosis of
CD and CS in the majority of patients. CD is confirmed
when a rapid response to a gluten-free diet is achieved [1],
however patients with CS generally do not respond to a
gluten-free diet [2]. In our case, the patient was diagnosed
with CD based upon serological and histological findings
with compatible clinical and laboratory manifestations
and noticeable clinical improvement was observed on a
gluten-free diet within several days.
CD may be associated with arthritis in some patients [3].
Articular involvement is peripheral in 19 percent, axial in
15 percent, and combined in 18 percent. The arthritis is
typically nonerosive and can be either oligoarticular or
polyarticular. Joint symptoms may precede gastrointesti-
nal manifestations of the disease and respond to a gluten
free diet. Our patient had been misdiagnosed to have
seronegative arthritis and had not been accurately treated
since several years.
Bone loss (principally osteopenia and less often oste-
oporosis) is common in CD [4] and much of the bone loss
is related to secondary hyperparathyroidism, which is
probably due to vitamin D deficiency [5]. A low serum
25(OH) D concentration is the hallmark of vitamin D
deficiency, which leads to hypocalcemia and hypophos-
phatemia. Hypocalcemia stimulates the release of PTH,
resulting in increased effect of PTH on bone. PTH also
enhances urinary phosphate excretion and contributes to
the development of hypophosphatemia. The biochemical
laboratory studies of our case were consistent with the
diagnosis of secondary hyperparathyroidism and she had
significantly decreased BMD in the lumbar spine and fem-
oral neck. Calcium and vitamin D supplements were ini-
tiated to reduce the risk of bone loss and fractures and to
enhance the mineralization of bone. Additionally, the
patient was started on once-weekly bisphosphonate ther-
apy after her dyspeptic complaints abated.
It has previously been shown that CD may be associated
with neuropsychiatric symptoms such as depression or
anxiety [6]. Our case presented with prominent anxiety
and episodic headaches, and she was started on an anxio-
lytic medication.
Increased prevalence of coexisting thyroid disease (usu-
ally hypothyroidism and less often hyperthyroidism) has
been reported among patients with celiac disease [7]. In
our patient, serum TSH levels did not increase despite the
low FT4 and low-normal FT3 values.
Our patient presented with weight loss, diarrhea, weak-
ness, and fatigue. On physical examination, cachexia and
pretibial edema were detected. Laboratory studies
revealed hypoalbuminemia with normal daily protein
excretion of less than 150 mg and elevated levels of alka-
line phosphatase and gammaglutamyl transpeptidase.
Abdominal ultrasonography revealed hepatomegaly and
increased echogenicity of the parenchyma. These symp-
toms and findings may all be suggestive of the contribu-
tion of gastrointestinal amyloidosis to malabsorption [8],
protein-losing gastroenteropathy [9] and probably to
hepatic involvement [10]. Additionally, histological
examination of duodenal mucosa was consistent with
diagnosis of amyloidosis, but further immunohistochem-
ical studies showed no amyloid protein.
Conclusion
Although, CD is rarely reported to be associated with CS,
it should always be in mind as a possible cause for symp-
toms. This relationship is rare but it should be considered
among the differential diagnoses of chronic diarrhea with
progressive malabsorption and clinical follow-up in spe-
cialized centers is warranted in the management of these
cases. Patients with CS are generally considered to be glu-
Light-green staining of the deposition (Trichrome staining,  200× magnification) Figure 2
Light-green staining of the deposition (Trichrome 
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ten insensitive and often to have a poor prognosis, but
luckily gluten sensitivity differs from patient to patient
and it may, in some instances, be a completely reversible
small intestinal disorder.
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